Browsing Tag
Galderma
11 posts
Galderma share buyback: CHF 232m repurchase follows full exit by EQT, ADIA, and Auba Investment
Galderma repurchases CHF 232M in shares as EQT exits. Discover what the buyback and ownership shift mean for the dermatology company and investors.
Sensitive skin in the city: Galderma’s China study links pollution, stress, and poor sleep to lasting damage
Galderma’s EADV 2025 study shows how modern urban living worsens sensitive skin through inflammation, oxidative stress, and visible damage.
Can Galderma’s Alastin expansion in China reshape the future of perioperative skincare?
Galderma launches Alastin skincare in China, targeting the booming perioperative aesthetics market with science-backed formulations.
Galderma’s Nemluvio gains FDA nod for moderate-to-severe atopic dermatitis
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of Nemluvio (nemolizumab)…
Galderma’s nemolizumab sets new standard in prurigo nodularis treatment with OLYMPIA 1 trial success
Galderma’s latest clinical trial has unveiled a significant breakthrough in treating prurigo nodularis, a chronic neuroimmune skin condition…
Galderma’s breakthrough drug Nemluvio gains rapid FDA approval for severe itch condition
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for…
Galderma and L’Oréal join forces to advance dermatology
Galderma, renowned for its leadership in dermatology, and L’Oréal, a giant in beauty and skincare, have unveiled a…
Sun Pharma expands skincare play with $99m Alchemee acquisition from Galderma
Sun Pharmaceutical acquires Alchemee from Galderma in a $99.28M deal, gaining iconic acne brands like Proactiv. Find out how this boosts its skincare strategy.
Zydus Cadila gets FDA tentative approval for acne treatment generic
Zydus Cadila has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Adapalene and…
Alembic Pharmaceuticals gets FDA approval for Metronidazole Gel USP, 1 %
Alembic Pharmaceuticals said that its joint venture – Aleor Dermaceuticals has secured tentative approval from the US Food…